Correction : Evaluating the Predictive Value of Oxylipins for Cognitive Measures And White Matter Hyperintensities in Alzheimer’S Disease Continuum Compared to Conventional Beta‑Amyloid and Tau Protein Biomarkers (Molecular Neurobiology, (2025), 62, 11, (14156-14166), 10.1007/S12035-025-05185-W)

Correction : Evaluating the Predictive Value of Oxylipins for Cognitive Measures And White Matter Hyperintensities in Alzheimer’S Disease Continuum Compared to Conventional Beta‑Amyloid and Tau Protein Biomarkers (Molecular Neurobiology, (2025), 62, 11, (14156-14166), 10.1007/S12035-025-05185-W) Publisher Pubmed

Haghighi AS ; Mayeli M ; Ramezannezhad E ; Pouroushaninia N ; Parizi RB ; Nourollahifoumeshi M ; Idelkhani N ; Dadjou Z ; Saeedipour N ; Safaee N ; Partoandaz H ; Shafie M ; Sadeghi M ; Falahati M

Source: Molecular Neurobiology Published:2025

Abstract

In the original version of this article, the author group is missing the institutional author for the Alzheimer's Disease Neuroimaging Initiative and should be reinstated. The original article has been corrected. © 2025 Elsevier B.V., All rights reserved.

Related Docs

View other Related Docs

1. Correction To: Programmed Cell Death 1 (Pdcd1) Gene Haplotypes and Susceptibility of Patients to Basal Cell Carcinoma (Molecular Biology Reports, (2021), 48, 3, (2047-2052), 10.1007/S11033-020-06115-W), Molecular Biology Reports (2021)

2. Correction To: Honey Protects Against Chronic Unpredictable Mild Stress Induced- Intestinal Barrier Disintegration and Hepatic Inflammation (Molecular Biology Reports, (2020), 47, 11, (8475-8484), 10.1007/S11033-020-05888-4), Molecular Biology Reports (2021)

3. Correction To: The Effect of Vitamin D and Magnesium Supplementation on the Mental Health Status of Attention-Deficit Hyperactive Children: A Randomized Controlled Trial (Bmc Pediatrics, (2021), 21, 1, (178), 10.1186/S12887-021-02631-1), BMC Pediatrics (2021)

Experts (# of related papers)

Gholamreza Askari (1)

Maedeh Ghasemi (1)

Style	Citing Format
MLA	Haghighi AS, et al.. "Correction : Evaluating the Predictive Value of Oxylipins for Cognitive Measures And White Matter Hyperintensities in Alzheimer’S Disease Continuum Compared to Conventional Beta‑Amyloid and Tau Protein Biomarkers (Molecular Neurobiology, (2025), 62, 11, (14156-14166), 10.1007/S12035-025-05185-W)." Molecular Neurobiology, vol. 62, no. 12, 2025, pp. 16684-.
APA	Haghighi AS, Mayeli M, Ramezannezhad E, Pouroushaninia N, Parizi RB, Nourollahifoumeshi M, Idelkhani N, Dadjou Z, Saeedipour N, Safaee N, Partoandaz H, Shafie M, Sadeghi M, Falahati M (2025). Correction : Evaluating the Predictive Value of Oxylipins for Cognitive Measures And White Matter Hyperintensities in Alzheimer’S Disease Continuum Compared to Conventional Beta‑Amyloid and Tau Protein Biomarkers (Molecular Neurobiology, (2025), 62, 11, (14156-14166), 10.1007/S12035-025-05185-W). Molecular Neurobiology, 62(12), 16684-.
Chicago	Haghighi AS, Mayeli M, Ramezannezhad E, Pouroushaninia N, Parizi RB, Nourollahifoumeshi M, Idelkhani N, et al.. "Correction : Evaluating the Predictive Value of Oxylipins for Cognitive Measures And White Matter Hyperintensities in Alzheimer’S Disease Continuum Compared to Conventional Beta‑Amyloid and Tau Protein Biomarkers (Molecular Neurobiology, (2025), 62, 11, (14156-14166), 10.1007/S12035-025-05185-W)." Molecular Neurobiology 62, no. 12 (2025): 16684-.
Harvard	Haghighi AS et al. (2025) 'Correction : Evaluating the Predictive Value of Oxylipins for Cognitive Measures And White Matter Hyperintensities in Alzheimer’S Disease Continuum Compared to Conventional Beta‑Amyloid and Tau Protein Biomarkers (Molecular Neurobiology, (2025), 62, 11, (14156-14166), 10.1007/S12035-025-05185-W)', Molecular Neurobiology, 62(12), pp. 16684-.
Vancouver	Haghighi AS, Mayeli M, Ramezannezhad E, Pouroushaninia N, Parizi RB, Nourollahifoumeshi M, et al.. Correction : Evaluating the Predictive Value of Oxylipins for Cognitive Measures And White Matter Hyperintensities in Alzheimer’S Disease Continuum Compared to Conventional Beta‑Amyloid and Tau Protein Biomarkers (Molecular Neurobiology, (2025), 62, 11, (14156-14166), 10.1007/S12035-025-05185-W). Molecular Neurobiology. 2025;62(12):16684-.
BibTex	@article{ author = {Haghighi AS and Mayeli M and Ramezannezhad E and Pouroushaninia N and Parizi RB and Nourollahifoumeshi M and Idelkhani N and Dadjou Z and Saeedipour N and Safaee N and Partoandaz H and Shafie M and Sadeghi M and Falahati M}, title = {Correction : Evaluating the Predictive Value of Oxylipins for Cognitive Measures And White Matter Hyperintensities in Alzheimer’S Disease Continuum Compared to Conventional Beta‑Amyloid and Tau Protein Biomarkers (Molecular Neurobiology, (2025), 62, 11, (14156-14166), 10.1007/S12035-025-05185-W)}, journal = {Molecular Neurobiology}, volume = {62}, number = {12}, pages = {16684-}, year = {2025} }
RIS	TY - JOUR AU - Haghighi AS AU - Mayeli M AU - Ramezannezhad E AU - Pouroushaninia N AU - Parizi RB AU - Nourollahifoumeshi M AU - Idelkhani N AU - Dadjou Z AU - Saeedipour N AU - Safaee N AU - Partoandaz H AU - Shafie M AU - Sadeghi M AU - Falahati M TI - Correction : Evaluating the Predictive Value of Oxylipins for Cognitive Measures And White Matter Hyperintensities in Alzheimer’S Disease Continuum Compared to Conventional Beta‑Amyloid and Tau Protein Biomarkers (Molecular Neurobiology, (2025), 62, 11, (14156-14166), 10.1007/S12035-025-05185-W) JO - Molecular Neurobiology VL - 62 IS - 12 SP - 16684 EP - PY - 2025 ER -

Style

Citing Format

MLA

Haghighi AS, et al.. "Correction : Evaluating the Predictive Value of Oxylipins for Cognitive Measures And White Matter Hyperintensities in Alzheimer’S Disease Continuum Compared to Conventional Beta‑Amyloid and Tau Protein Biomarkers (Molecular Neurobiology, (2025), 62, 11, (14156-14166), 10.1007/S12035-025-05185-W)." Molecular Neurobiology, vol. 62, no. 12, 2025, pp. 16684-.

APA

Haghighi AS, Mayeli M, Ramezannezhad E, Pouroushaninia N, Parizi RB, Nourollahifoumeshi M, Idelkhani N, Dadjou Z, Saeedipour N, Safaee N, Partoandaz H, Shafie M, Sadeghi M, Falahati M (2025). Correction : Evaluating the Predictive Value of Oxylipins for Cognitive Measures And White Matter Hyperintensities in Alzheimer’S Disease Continuum Compared to Conventional Beta‑Amyloid and Tau Protein Biomarkers (Molecular Neurobiology, (2025), 62, 11, (14156-14166), 10.1007/S12035-025-05185-W). Molecular Neurobiology, 62(12), 16684-.

Chicago

Haghighi AS, Mayeli M, Ramezannezhad E, Pouroushaninia N, Parizi RB, Nourollahifoumeshi M, Idelkhani N, et al.. "Correction : Evaluating the Predictive Value of Oxylipins for Cognitive Measures And White Matter Hyperintensities in Alzheimer’S Disease Continuum Compared to Conventional Beta‑Amyloid and Tau Protein Biomarkers (Molecular Neurobiology, (2025), 62, 11, (14156-14166), 10.1007/S12035-025-05185-W)." Molecular Neurobiology 62, no. 12 (2025): 16684-.

Harvard

Haghighi AS et al. (2025) 'Correction : Evaluating the Predictive Value of Oxylipins for Cognitive Measures And White Matter Hyperintensities in Alzheimer’S Disease Continuum Compared to Conventional Beta‑Amyloid and Tau Protein Biomarkers (Molecular Neurobiology, (2025), 62, 11, (14156-14166), 10.1007/S12035-025-05185-W)', Molecular Neurobiology, 62(12), pp. 16684-.

Vancouver

Haghighi AS, Mayeli M, Ramezannezhad E, Pouroushaninia N, Parizi RB, Nourollahifoumeshi M, et al.. Correction : Evaluating the Predictive Value of Oxylipins for Cognitive Measures And White Matter Hyperintensities in Alzheimer’S Disease Continuum Compared to Conventional Beta‑Amyloid and Tau Protein Biomarkers (Molecular Neurobiology, (2025), 62, 11, (14156-14166), 10.1007/S12035-025-05185-W). Molecular Neurobiology. 2025;62(12):16684-.

BibTex

@article{ author = {Haghighi AS and Mayeli M and Ramezannezhad E and Pouroushaninia N and Parizi RB and Nourollahifoumeshi M and Idelkhani N and Dadjou Z and Saeedipour N and Safaee N and Partoandaz H and Shafie M and Sadeghi M and Falahati M}, title = {Correction : Evaluating the Predictive Value of Oxylipins for Cognitive Measures And White Matter Hyperintensities in Alzheimer’S Disease Continuum Compared to Conventional Beta‑Amyloid and Tau Protein Biomarkers (Molecular Neurobiology, (2025), 62, 11, (14156-14166), 10.1007/S12035-025-05185-W)}, journal = {Molecular Neurobiology}, volume = {62}, number = {12}, pages = {16684-}, year = {2025} }

RIS

TY - JOUR
AU - Haghighi AS
AU - Mayeli M
AU - Ramezannezhad E
AU - Pouroushaninia N
AU - Parizi RB
AU - Nourollahifoumeshi M
AU - Idelkhani N
AU - Dadjou Z
AU - Saeedipour N
AU - Safaee N
AU - Partoandaz H
AU - Shafie M
AU - Sadeghi M
AU - Falahati M
TI - Correction : Evaluating the Predictive Value of Oxylipins for Cognitive Measures And White Matter Hyperintensities in Alzheimer’S Disease Continuum Compared to Conventional Beta‑Amyloid and Tau Protein Biomarkers (Molecular Neurobiology, (2025), 62, 11, (14156-14166), 10.1007/S12035-025-05185-W)
JO - Molecular Neurobiology
VL - 62
IS - 12
SP - 16684
EP -
PY - 2025
ER -

Science Communicator Platform

Authors

Abstract